RU2004104329A - Ацилсемикарбазиды как ингибиторы циклинзависимой киназы, полезные в качестве противораковых и противопролиферативных агентов - Google Patents
Ацилсемикарбазиды как ингибиторы циклинзависимой киназы, полезные в качестве противораковых и противопролиферативных агентов Download PDFInfo
- Publication number
- RU2004104329A RU2004104329A RU2004104329/04A RU2004104329A RU2004104329A RU 2004104329 A RU2004104329 A RU 2004104329A RU 2004104329/04 A RU2004104329/04 A RU 2004104329/04A RU 2004104329 A RU2004104329 A RU 2004104329A RU 2004104329 A RU2004104329 A RU 2004104329A
- Authority
- RU
- Russia
- Prior art keywords
- substituted
- alkyl
- group
- nhc
- membered heterocycle
- Prior art date
Links
- 102000003903 Cyclin-dependent kinases Human genes 0.000 title 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 230000001028 anti-proliverative effect Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 87
- 229910052757 nitrogen Inorganic materials 0.000 claims 54
- 229910052717 sulfur Inorganic materials 0.000 claims 47
- 229910052799 carbon Inorganic materials 0.000 claims 45
- 125000000623 heterocyclic group Chemical group 0.000 claims 43
- 229910052760 oxygen Inorganic materials 0.000 claims 43
- 125000005842 heteroatom Chemical group 0.000 claims 39
- 229910052739 hydrogen Inorganic materials 0.000 claims 36
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 35
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 31
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 30
- 229910052736 halogen Inorganic materials 0.000 claims 28
- 150000002367 halogens Chemical class 0.000 claims 28
- 125000000304 alkynyl group Chemical group 0.000 claims 14
- -1 substituted 0-3 R c Chemical group 0.000 claims 14
- OYODOQNYJLSLJE-UHFFFAOYSA-N pyrazol-4-one Chemical compound O=C1C=NN=C1 OYODOQNYJLSLJE-UHFFFAOYSA-N 0.000 claims 12
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 8
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 7
- 125000004497 pyrazol-5-yl group Chemical group N1N=CC=C1* 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000004429 atom Chemical group 0.000 claims 4
- 239000004202 carbamide Substances 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims 4
- 125000004434 sulfur atom Chemical group 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 0 *c([n]nc1-c2c3c(NC(C(C4)C4=*)=*)ccc2)c1C3=O Chemical compound *c([n]nc1-c2c3c(NC(C(C4)C4=*)=*)ccc2)c1C3=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/906,963 US6593356B2 (en) | 1999-10-20 | 2001-07-16 | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| US09/906,963 | 2001-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2004104329A true RU2004104329A (ru) | 2005-07-10 |
Family
ID=25423309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004104329/04A RU2004104329A (ru) | 2001-07-16 | 2002-07-16 | Ацилсемикарбазиды как ингибиторы циклинзависимой киназы, полезные в качестве противораковых и противопролиферативных агентов |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6593356B2 (https=) |
| EP (1) | EP1417177A4 (https=) |
| JP (1) | JP2004536853A (https=) |
| KR (1) | KR20040015368A (https=) |
| CN (1) | CN1553900A (https=) |
| BR (1) | BR0211203A (https=) |
| CA (1) | CA2453594A1 (https=) |
| HU (1) | HUP0401588A3 (https=) |
| IL (1) | IL159863A0 (https=) |
| MX (1) | MXPA04000531A (https=) |
| NO (1) | NO20040175L (https=) |
| PL (1) | PL366912A1 (https=) |
| RU (1) | RU2004104329A (https=) |
| WO (1) | WO2003007883A2 (https=) |
| ZA (1) | ZA200400332B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040048844A1 (en) * | 1999-10-20 | 2004-03-11 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| JP3821090B2 (ja) * | 2002-10-22 | 2006-09-13 | トヨタ自動車株式会社 | 内燃機関の始動制御装置 |
| US7456169B2 (en) | 2003-02-27 | 2008-11-25 | Abbott Laboratories Inc. | Heterocyclic kinase inhibitors |
| US7320986B2 (en) | 2003-03-07 | 2008-01-22 | Abbott Labortories | Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| EP1740579B1 (en) | 2004-03-24 | 2015-08-19 | AbbVie Inc. | Tricyclic pyrazole kinase inhibitors |
| US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
| JP5795584B2 (ja) | 2009-08-31 | 2015-10-14 | アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． | 医療用装置 |
| ES2881798T3 (es) | 2010-03-24 | 2021-11-30 | Abbott Diabetes Care Inc | Insertadores de dispositivos médicos y procedimientos de inserción y uso de dispositivos médicos |
| AU2012352560B2 (en) | 2011-12-11 | 2017-01-19 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
| US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
| MX2018006250A (es) | 2015-11-18 | 2018-09-05 | Genzyme Corp | Biomarcador de enfermedad poliquistica renal y usos del mismo. |
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
| CN114641466B (zh) | 2019-06-12 | 2025-09-30 | 诺瑟拉有限公司 | 磺酰脲衍生物及其用途 |
| USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407103B2 (en) * | 1998-04-21 | 2002-06-18 | Bristol-Myers Squibb Pharma Company | Indeno [1,2-c] pyrazol-4-ones and their uses |
| JP4665239B2 (ja) | 1998-04-21 | 2011-04-06 | アゲンニクス アーゲー | 抗癌剤および抗増殖性薬剤としての５−アミノインデノ［１，２−ｃ］ピラゾール−４−オン |
| US6291504B1 (en) * | 1999-10-20 | 2001-09-18 | Dupont Pharmaceuticals Company | Acylsemicarbazides and their uses |
| AU2001212168A1 (en) * | 2000-10-20 | 2002-05-06 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides and their use as cyclin dependent kinase (CDK) inhibitors |
| WO2002044174A2 (en) * | 2000-12-01 | 2002-06-06 | Bristol-Myers Squibb Pharma Company | 3-(2,4-dimethylthiazol-5-yl) indeno[1,2-c]pyrazol-4-one derivatives as cdk inhibitors |
-
2001
- 2001-07-16 US US09/906,963 patent/US6593356B2/en not_active Expired - Lifetime
-
2002
- 2002-07-16 EP EP02748186A patent/EP1417177A4/en not_active Withdrawn
- 2002-07-16 CA CA002453594A patent/CA2453594A1/en not_active Abandoned
- 2002-07-16 HU HU0401588A patent/HUP0401588A3/hu unknown
- 2002-07-16 CN CNA028177614A patent/CN1553900A/zh active Pending
- 2002-07-16 MX MXPA04000531A patent/MXPA04000531A/es unknown
- 2002-07-16 IL IL15986302A patent/IL159863A0/xx unknown
- 2002-07-16 JP JP2003513492A patent/JP2004536853A/ja not_active Abandoned
- 2002-07-16 BR BR0211203-5A patent/BR0211203A/pt not_active IP Right Cessation
- 2002-07-16 PL PL02366912A patent/PL366912A1/xx not_active Application Discontinuation
- 2002-07-16 RU RU2004104329/04A patent/RU2004104329A/ru not_active Application Discontinuation
- 2002-07-16 KR KR10-2004-7000762A patent/KR20040015368A/ko not_active Withdrawn
- 2002-07-16 WO PCT/US2002/022663 patent/WO2003007883A2/en not_active Ceased
-
2004
- 2004-01-15 NO NO20040175A patent/NO20040175L/no unknown
- 2004-01-15 ZA ZA2004/00332A patent/ZA200400332B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6593356B2 (en) | 2003-07-15 |
| EP1417177A4 (en) | 2005-10-19 |
| NO20040175L (no) | 2004-03-12 |
| WO2003007883A3 (en) | 2003-05-22 |
| ZA200400332B (en) | 2005-06-29 |
| HUP0401588A3 (en) | 2005-06-28 |
| US20030073686A1 (en) | 2003-04-17 |
| EP1417177A2 (en) | 2004-05-12 |
| CA2453594A1 (en) | 2003-01-30 |
| WO2003007883A2 (en) | 2003-01-30 |
| BR0211203A (pt) | 2004-09-28 |
| HUP0401588A2 (hu) | 2005-01-28 |
| KR20040015368A (ko) | 2004-02-18 |
| CN1553900A (zh) | 2004-12-08 |
| JP2004536853A (ja) | 2004-12-09 |
| IL159863A0 (en) | 2004-06-20 |
| MXPA04000531A (es) | 2004-05-04 |
| PL366912A1 (en) | 2005-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2004104329A (ru) | Ацилсемикарбазиды как ингибиторы циклинзависимой киназы, полезные в качестве противораковых и противопролиферативных агентов | |
| GB0402653D0 (en) | Compounds | |
| TW200642685A (en) | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof | |
| JP2021152063A5 (https=) | ||
| SE0104332D0 (sv) | Therapeutic agents | |
| RU2003136731A (ru) | Новые производные индола со сродством к рецептору 5-нт6 | |
| JP2005509024A5 (https=) | ||
| JP2005504042A5 (https=) | ||
| RU2007123235A (ru) | Противоопухолевые соединения | |
| CA2436846A1 (en) | Thioether substituted imidazoquinolines | |
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ | |
| RU2011103741A (ru) | Композиции и способы лечения заболевания сетчатки | |
| MXPA04009784A (es) | Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas. | |
| EA200700099A1 (ru) | Производные пиридина | |
| EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
| RU2011127451A (ru) | ПРОИЗВОДНЫЕ ТИЕНО[3,2-c]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ РАКА | |
| JP2006511446A5 (https=) | ||
| JP2024509981A5 (https=) | ||
| RU2007116987A (ru) | Новые соединения | |
| RU2010107603A (ru) | Производные n-(2-тиазолил)амида для лечения ожирения, диабетов и сердечно-сосудистых заболеваний | |
| RU98119076A (ru) | Производные 2-(3h)-оксазолона и их применение в качестве ингибиторов сох-2 | |
| JP2004536853A5 (https=) | ||
| JP2018527324A5 (https=) | ||
| RU2007120710A (ru) | Способ лечения рака и/или лейкоза и применяемая в нем фармацевтическая композиция | |
| RU2005125919A (ru) | Альфа-аминоамидные производные, применимые в качестве антимигренозных средств |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20050929 |